Global Breast Cancer Predictive Genetic Testing Market Size, Status and Forecast 2020-2026

SKU ID :QYR-15447387 | Published Date: 13-Mar-2020 | No. of pages: 93
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Breast Cancer Predictive Genetic Testing Revenue 1.4 Market Analysis by Type 1.4.1 Global Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 High Penetrant Genes 1.4.3 Intermediate Penetrant Genes 1.4.4 Low Penetrant Genes 1.5 Market by Application 1.5.1 Global Breast Cancer Predictive Genetic Testing Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Breast Cancer Predictive Genetic Testing Market Perspective (2015-2026) 2.2 Breast Cancer Predictive Genetic Testing Growth Trends by Regions 2.2.1 Breast Cancer Predictive Genetic Testing Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Breast Cancer Predictive Genetic Testing Historic Market Share by Regions (2015-2020) 2.2.3 Breast Cancer Predictive Genetic Testing Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Breast Cancer Predictive Genetic Testing Market Growth Strategy 2.3.6 Primary Interviews with Key Breast Cancer Predictive Genetic Testing Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Breast Cancer Predictive Genetic Testing Players by Market Size 3.1.1 Global Top Breast Cancer Predictive Genetic Testing Players by Revenue (2015-2020) 3.1.2 Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Players (2015-2020) 3.1.3 Global Breast Cancer Predictive Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Breast Cancer Predictive Genetic Testing Market Concentration Ratio 3.2.1 Global Breast Cancer Predictive Genetic Testing Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Breast Cancer Predictive Genetic Testing Revenue in 2019 3.3 Breast Cancer Predictive Genetic Testing Key Players Head office and Area Served 3.4 Key Players Breast Cancer Predictive Genetic Testing Product Solution and Service 3.5 Date of Enter into Breast Cancer Predictive Genetic Testing Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Breast Cancer Predictive Genetic Testing Historic Market Size by Type (2015-2020) 4.2 Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Type (2021-2026) 5 Breast Cancer Predictive Genetic Testing Breakdown Data by Application (2015-2026) 5.1 Global Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020) 5.2 Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Breast Cancer Predictive Genetic Testing Market Size (2015-2020) 6.2 Breast Cancer Predictive Genetic Testing Key Players in North America (2019-2020) 6.3 North America Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020) 6.4 North America Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020) 7 Europe 7.1 Europe Breast Cancer Predictive Genetic Testing Market Size (2015-2020) 7.2 Breast Cancer Predictive Genetic Testing Key Players in Europe (2019-2020) 7.3 Europe Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020) 7.4 Europe Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020) 8 China 8.1 China Breast Cancer Predictive Genetic Testing Market Size (2015-2020) 8.2 Breast Cancer Predictive Genetic Testing Key Players in China (2019-2020) 8.3 China Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020) 8.4 China Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020) 9 Japan 9.1 Japan Breast Cancer Predictive Genetic Testing Market Size (2015-2020) 9.2 Breast Cancer Predictive Genetic Testing Key Players in Japan (2019-2020) 9.3 Japan Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020) 9.4 Japan Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Breast Cancer Predictive Genetic Testing Market Size (2015-2020) 10.2 Breast Cancer Predictive Genetic Testing Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020) 10.4 Southeast Asia Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020) 11 India 11.1 India Breast Cancer Predictive Genetic Testing Market Size (2015-2020) 11.2 Breast Cancer Predictive Genetic Testing Key Players in India (2019-2020) 11.3 India Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020) 11.4 India Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Breast Cancer Predictive Genetic Testing Market Size (2015-2020) 12.2 Breast Cancer Predictive Genetic Testing Key Players in Central & South America (2019-2020) 12.3 Central & South America Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020) 12.4 Central & South America Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Roche 13.1.1 Roche Company Details 13.1.2 Roche Business Overview and Its Total Revenue 13.1.3 Roche Breast Cancer Predictive Genetic Testing Introduction 13.1.4 Roche Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020)) 13.1.5 Roche Recent Development 13.2 Thermo Fisher Scientific 13.2.1 Thermo Fisher Scientific Company Details 13.2.2 Thermo Fisher Scientific Business Overview and Its Total Revenue 13.2.3 Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Introduction 13.2.4 Thermo Fisher Scientific Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020) 13.2.5 Thermo Fisher Scientific Recent Development 13.3 PerkinElmer 13.3.1 PerkinElmer Company Details 13.3.2 PerkinElmer Business Overview and Its Total Revenue 13.3.3 PerkinElmer Breast Cancer Predictive Genetic Testing Introduction 13.3.4 PerkinElmer Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020) 13.3.5 PerkinElmer Recent Development 13.4 Quest Diagnostics 13.4.1 Quest Diagnostics Company Details 13.4.2 Quest Diagnostics Business Overview and Its Total Revenue 13.4.3 Quest Diagnostics Breast Cancer Predictive Genetic Testing Introduction 13.4.4 Quest Diagnostics Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020) 13.4.5 Quest Diagnostics Recent Development 13.5 Myriad Genetics 13.5.1 Myriad Genetics Company Details 13.5.2 Myriad Genetics Business Overview and Its Total Revenue 13.5.3 Myriad Genetics Breast Cancer Predictive Genetic Testing Introduction 13.5.4 Myriad Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020) 13.5.5 Myriad Genetics Recent Development 13.6 Iverson Genetics 13.6.1 Iverson Genetics Company Details 13.6.2 Iverson Genetics Business Overview and Its Total Revenue 13.6.3 Iverson Genetics Breast Cancer Predictive Genetic Testing Introduction 13.6.4 Iverson Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020) 13.6.5 Iverson Genetics Recent Development 13.7 Cancer Genetics 13.7.1 Cancer Genetics Company Details 13.7.2 Cancer Genetics Business Overview and Its Total Revenue 13.7.3 Cancer Genetics Breast Cancer Predictive Genetic Testing Introduction 13.7.4 Cancer Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020) 13.7.5 Cancer Genetics Recent Development 13.8 OncoCyte Corporation 13.8.1 OncoCyte Corporation Company Details 13.8.2 OncoCyte Corporation Business Overview and Its Total Revenue 13.8.3 OncoCyte Corporation Breast Cancer Predictive Genetic Testing Introduction 13.8.4 OncoCyte Corporation Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020) 13.8.5 OncoCyte Corporation Recent Development 13.9 NeoGenomics 13.9.1 NeoGenomics Company Details 13.9.2 NeoGenomics Business Overview and Its Total Revenue 13.9.3 NeoGenomics Breast Cancer Predictive Genetic Testing Introduction 13.9.4 NeoGenomics Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020) 13.9.5 NeoGenomics Recent Development 13.10 Invitae 13.10.1 Invitae Company Details 13.10.2 Invitae Business Overview and Its Total Revenue 13.10.3 Invitae Breast Cancer Predictive Genetic Testing Introduction 13.10.4 Invitae Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020) 13.10.5 Invitae Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details
List of Tables Table 1. Breast Cancer Predictive Genetic Testing Key Market Segments Table 2. Key Players Covered: Ranking by Breast Cancer Predictive Genetic Testing Revenue Table 3. Ranking of Global Top Breast Cancer Predictive Genetic Testing Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of High Penetrant Genes Table 6. Key Players of Intermediate Penetrant Genes Table 7. Key Players of Low Penetrant Genes Table 8. Global Breast Cancer Predictive Genetic Testing Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Breast Cancer Predictive Genetic Testing Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Breast Cancer Predictive Genetic Testing Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Breast Cancer Predictive Genetic Testing Market Share by Regions (2015-2020) Table 12. Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Breast Cancer Predictive Genetic Testing Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. Breast Cancer Predictive Genetic Testing Market Growth Strategy Table 18. Main Points Interviewed from Key Breast Cancer Predictive Genetic Testing Players Table 19. Global Breast Cancer Predictive Genetic Testing Revenue by Players (2015-2020) (Million US$) Table 20. Global Breast Cancer Predictive Genetic Testing Market Share by Players (2015-2020) Table 21. Global Top Breast Cancer Predictive Genetic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Predictive Genetic Testing as of 2019) Table 22. Global Breast Cancer Predictive Genetic Testing by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Breast Cancer Predictive Genetic Testing Product Solution and Service Table 25. Date of Enter into Breast Cancer Predictive Genetic Testing Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020) (Million US$) Table 28. Global Breast Cancer Predictive Genetic Testing Market Size Share by Type (2015-2020) Table 29. Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Type (2021-2026) Table 30. Global Breast Cancer Predictive Genetic Testing Market Size Share by Application (2015-2020) Table 31. Global Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020) (Million US$) Table 32. Global Breast Cancer Predictive Genetic Testing Market Size Share by Application (2021-2026) Table 33. North America Key Players Breast Cancer Predictive Genetic Testing Revenue (2019-2020) (Million US$) Table 34. North America Key Players Breast Cancer Predictive Genetic Testing Market Share (2019-2020) Table 35. North America Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020) (Million US$) Table 36. North America Breast Cancer Predictive Genetic Testing Market Share by Type (2015-2020) Table 37. North America Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020) (Million US$) Table 38. North America Breast Cancer Predictive Genetic Testing Market Share by Application (2015-2020) Table 39. Europe Key Players Breast Cancer Predictive Genetic Testing Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Breast Cancer Predictive Genetic Testing Market Share (2019-2020) Table 41. Europe Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020) (Million US$) Table 42. Europe Breast Cancer Predictive Genetic Testing Market Share by Type (2015-2020) Table 43. Europe Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020) (Million US$) Table 44. Europe Breast Cancer Predictive Genetic Testing Market Share by Application (2015-2020) Table 45. China Key Players Breast Cancer Predictive Genetic Testing Revenue (2019-2020) (Million US$) Table 46. China Key Players Breast Cancer Predictive Genetic Testing Market Share (2019-2020) Table 47. China Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020) (Million US$) Table 48. China Breast Cancer Predictive Genetic Testing Market Share by Type (2015-2020) Table 49. China Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020) (Million US$) Table 50. China Breast Cancer Predictive Genetic Testing Market Share by Application (2015-2020) Table 51. Japan Key Players Breast Cancer Predictive Genetic Testing Revenue (2019-2020) (Million US$) Table 52. Japan Key Players Breast Cancer Predictive Genetic Testing Market Share (2019-2020) Table 53. Japan Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020) (Million US$) Table 54. Japan Breast Cancer Predictive Genetic Testing Market Share by Type (2015-2020) Table 55. Japan Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020) (Million US$) Table 56. Japan Breast Cancer Predictive Genetic Testing Market Share by Application (2015-2020) Table 57. Southeast Asia Key Players Breast Cancer Predictive Genetic Testing Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players Breast Cancer Predictive Genetic Testing Market Share (2019-2020) Table 59. Southeast Asia Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020) (Million US$) Table 60. Southeast Asia Breast Cancer Predictive Genetic Testing Market Share by Type (2015-2020) Table 61. Southeast Asia Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020) (Million US$) Table 62. Southeast Asia Breast Cancer Predictive Genetic Testing Market Share by Application (2015-2020) Table 63. India Key Players Breast Cancer Predictive Genetic Testing Revenue (2019-2020) (Million US$) Table 64. India Key Players Breast Cancer Predictive Genetic Testing Market Share (2019-2020) Table 65. India Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020) (Million US$) Table 66. India Breast Cancer Predictive Genetic Testing Market Share by Type (2015-2020) Table 67. India Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020) (Million US$) Table 68. India Breast Cancer Predictive Genetic Testing Market Share by Application (2015-2020) Table 69. Central & South America Key Players Breast Cancer Predictive Genetic Testing Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players Breast Cancer Predictive Genetic Testing Market Share (2019-2020) Table 71. Central & South America Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020) (Million US$) Table 72. Central & South America Breast Cancer Predictive Genetic Testing Market Share by Type (2015-2020) Table 73. Central & South America Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020) (Million US$) Table 74. Central & South America Breast Cancer Predictive Genetic Testing Market Share by Application (2015-2020) Table 75. Roche Company Details Table 76. Roche Business Overview Table 77. Roche Product Table 78. Roche Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020) (Million US$) Table 79. Roche Recent Development Table 80. Thermo Fisher Scientific Company Details Table 81. Thermo Fisher Scientific Business Overview Table 82. Thermo Fisher Scientific Product Table 83. Thermo Fisher Scientific Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020) (Million US$) Table 84. Thermo Fisher Scientific Recent Development Table 85. PerkinElmer Company Details Table 86. PerkinElmer Business Overview Table 87. PerkinElmer Product Table 88. PerkinElmer Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020) (Million US$) Table 89. PerkinElmer Recent Development Table 90. Quest Diagnostics Company Details Table 91. Quest Diagnostics Business Overview Table 92. Quest Diagnostics Product Table 93. Quest Diagnostics Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020) (Million US$) Table 94. Quest Diagnostics Recent Development Table 95. Myriad Genetics Company Details Table 96. Myriad Genetics Business Overview Table 97. Myriad Genetics Product Table 98. Myriad Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020) (Million US$) Table 99. Myriad Genetics Recent Development Table 100. Iverson Genetics Company Details Table 101. Iverson Genetics Business Overview Table 102. Iverson Genetics Product Table 103. Iverson Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020) (Million US$) Table 104. Iverson Genetics Recent Development Table 105. Cancer Genetics Company Details Table 106. Cancer Genetics Business Overview Table 107. Cancer Genetics Product Table 108. Cancer Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020) (Million US$) Table 109. Cancer Genetics Recent Development Table 110. OncoCyte Corporation Business Overview Table 111. OncoCyte Corporation Product Table 112. OncoCyte Corporation Company Details Table 113. OncoCyte Corporation Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020) (Million US$) Table 114. OncoCyte Corporation Recent Development Table 115. NeoGenomics Company Details Table 116. NeoGenomics Business Overview Table 117. NeoGenomics Product Table 118. NeoGenomics Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020) (Million US$) Table 119. NeoGenomics Recent Development Table 120. Invitae Company Details Table 121. Invitae Business Overview Table 122. Invitae Product Table 123. Invitae Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020) (Million US$) Table 124. Invitae Recent Development Table 125. Research Programs/Design for This Report Table 126. Key Data Information from Secondary Sources Table 127. Key Data Information from Primary Sources List of Figures Figure 1. Global Breast Cancer Predictive Genetic Testing Market Share by Type: 2020 VS 2026 Figure 2. High Penetrant Genes Features Figure 3. Intermediate Penetrant Genes Features Figure 4. Low Penetrant Genes Features Figure 5. Global Breast Cancer Predictive Genetic Testing Market Share by Application: 2020 VS 2026 Figure 6. Hospitals Case Studies Figure 7. Clinics Case Studies Figure 8. Other Case Studies Figure 9. Breast Cancer Predictive Genetic Testing Report Years Considered Figure 10. Global Breast Cancer Predictive Genetic Testing Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global Breast Cancer Predictive Genetic Testing Market Share by Regions: 2020 VS 2026 Figure 12. Global Breast Cancer Predictive Genetic Testing Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global Breast Cancer Predictive Genetic Testing Market Share by Players in 2019 Figure 15. Global Top Breast Cancer Predictive Genetic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Predictive Genetic Testing as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Breast Cancer Predictive Genetic Testing Revenue in 2019 Figure 17. North America Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2015-2020) (Million US$) Figure 19. China Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Japan Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Southeast Asia Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2015-2020) (Million US$) Figure 22. India Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Central & South America Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Roche Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2015-2020) Figure 26. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Thermo Fisher Scientific Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2015-2020) Figure 28. PerkinElmer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. PerkinElmer Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2015-2020) Figure 30. Quest Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Quest Diagnostics Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2015-2020) Figure 32. Myriad Genetics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Myriad Genetics Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2015-2020) Figure 34. Iverson Genetics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Iverson Genetics Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2015-2020) Figure 36. Cancer Genetics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Cancer Genetics Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2015-2020) Figure 38. OncoCyte Corporation Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. OncoCyte Corporation Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2015-2020) Figure 40. NeoGenomics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. NeoGenomics Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2015-2020) Figure 42. Invitae Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Invitae Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2015-2020) Figure 44. Bottom-up and Top-down Approaches for This Report Figure 45. Data Triangulation Figure 46. Key Executives Interviewed
Roche Thermo Fisher Scientific PerkinElmer Quest Diagnostics Myriad Genetics Iverson Genetics Cancer Genetics OncoCyte Corporation NeoGenomics Invitae
  • PRICE
  • $3900
    $7800
    $5850
    Buy Now

Our Clients